ARTICLE | Clinical News
Pimagedine: Received FDA clearance to discontinue endoscopies
September 6, 1994 7:00 AM UTC
Alteon Inc. (ALTN), Ramsey, N.J., and Marion Merrell Dow Product: Pimagedine, to prevent formation of advanced glycosylation end products linked to diabetic complications Indication: Overt diabetic n...